Summary SOM Biotech SL (SOM Biotech) is a drug repurposing company that discovers and develops new drugs for orphan indications.The company’s pipeline products include SOM0777, SOM0226, SOM3355, SOM1201 and SOM2201 are used for the treatment of TTR amyloidosis, glioblastoma, huntington disease, duchenne muscular dystrophy and adrenoleukodystrophy.
It also provides services such as drug discovery, patenting, pre-clinical validation, clinical proof of concept and licensing of known drugs.SOM Biotech’s product finds application in the areas of neurology, metabolic disorders, urology and oncology related orphan diseases.
The company offers a virtual screening technology solution that identifies biological activities of drug.Its business model is based in licensing and joint-venture agreements for the development of repurposed drugs.
SOM Biotech is headquartered in Barcelona, Spain.
SOM Biotech SL - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings.The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period.
The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope - Financial Deals - Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company’s operations. - Key Employees - A list of the key executives of the company. - Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company. - Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company.
Reasons to Buy Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements - The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy - The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Our reports have been used by over 10K customers, including:
The global microplate systems market size is projected to reach USD 1,170 million by 2026 from USD 927 million in 2021, at a CAGR of 4.8% from 2021 to 2026. Growth in this market is driven by the increasing R&D expenditure in the pharmaceutical industry, increasing focus on miniaturization, and the growing prevalence of diseases Microplate...
175 pages •
By The Business Research Company
• May 2021
Major players in the biotechnology services market are Novartis, Fisher BioService, Pfizer, Novo Nordisk, BioAlps, Precision for Medicine, Sartorius, and Aldevron. The global biotechnology services market is expected to grow from $150.37 billion in 2020 to $163.92 billion in 2021 at a compound annual growth rate (CAGR) of 9%. The growth...
The Global Asset Purchase Deals in Pharma, Biotech and Diagnostics 2014-2021 report provides a detailed understanding and analysis of how and why companies enter business, product, technology and royalty assets. The report provides a detailed understanding and analysis of how and why companies enter business, product,...
173 pages •
By Global Industry Analysts
• Apr 2021
- Global D-dimer Testing Market to Reach $2.7 Billion by 2027
- Amid the COVID-19 crisis, the global market for D-dimer Testing estimated at US$2.1 Billion in the year 2020, is projected to reach a revised size of US$2.7 Billion by 2027, growing at aCAGR of 3.8% over the period 2020-2027. Point-of-Care Tests,...
Histone Deacetylase 8 (Histone Deacetylase Like 1 or HDAC8 or EC 126.96.36.199) - Drugs in Development, 2021 Summary Histone Deacetylase 8 (Histone Deacetylase Like 1 or HDAC8 or EC 188.8.131.52) - Histone deacetylase 8 is an enzyme encoded by the HDAC8 gene. It is responsible for the deacetylation of lysine...
The Asia Pacific microplate readers market is expected to reach US$ 152.15 million by 2027 from US$ 110.87 million in 2019; it is estimated to grow at a CAGR of 4.1% from 2020 to 2027. The growth of the market is attributed to the factors such as technological advancements in microplate readers and consistent research in drug discovery activities....
The Middle East and Africa microplate readers market is expected to reach US$ 19.79 million by 2027 from US$ 16.24 million in 2019; it is estimated to grow with a CAGR of 2.6% from 2020 to 2027. The growth of the market is attributed to some key driving factors such as increasing incidence of infectious diseases and consistent research in...
479 pages •
By Global Industry Analysts
• May 2021
Global Collagen Peptides Market to Reach $822.9 Million by 2027
Amid the COVID-19 crisis, the global market for Collagen Peptides estimated at US$564.4 Million in the year 2020, is projected to reach a revised size of US$822.9 Million by 2027, growing at a CAGR of 5.5% over the analysis...
120 pages •
By Infiniti Research Limited
• Mar 2021
Global Pharmacovigilance And Drug Safety Software Market 2021-2025 The analyst has been monitoring the pharmacovigilance and drug safety software market and it is poised to grow by $ 66.51 mn during 2021-2025 progressing at a CAGR of 7% during the forecast period. Our report on pharmacovigilance and drug safety software...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.